Article
Chromatin signalling pathways and FANCE amplification affect ATR inhibitor sensitivity in metastatic breast cancer
2025-08-31
Abstract excerpt
<h4>ABSTRACT</h4> Metastatic breast cancer remains incurable, as many patients develop therapy resistance. Loss of ATM/p53 increases reliance on the ATR pathway, positioning ATR inhibitors (ATRi) as promising therapeutics. However, targeting a single pathway often leads to resistance due to tumour heterogeneity or alternative signalling mechanisms. Here, we combine chromatin-enrichment proteomics and phospho-prot...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0a8e8c90-218b-5bd8-9643-f5efa47040be
- DOI
- 10.1101/2025.08.26.672363
